BioHarvest (BHST) Q1 2026 Earnings Call Transcript

During BioHarvest's first-quarter earnings call, CEO Zaki Rakib highlighted the company’s progress in its Botanical Synthesis platform and dual business model. The D2C segment has generated nearly $100 million in VINIA-based sales to date, while the CDMO division is expanding across multiple markets.

By Motley Fool Transcribing, The Motley Fool Mon, May 18, 2026 at 4:08 PM GMT+3 43 min read · Yahoo Finance · May 18, 2026, 13:08 UTC

BioHarvest (BHST) Q1 2026 Earnings Call Transcript

Topics: biotech CDMO D2C sales plant cell culture

Read the full article at Yahoo Finance

More World news

BlueMatrix Completes Acquisition of AI-Enabled Research Platform Aiera PR Newswire · November 12, 2026, 15:15 UTC
U.S. Lawmakers Respond to Jensen Huang's Resignation as Nvidia CEO Seeking Alpha · November 12, 2026, 15:12 UTC
OpenAI Secures $15 Billion in New Funding at $1.25 Trillion Valuation Seeking Alpha · November 12, 2026, 15:13 UTC
Digi International Shares Fall 18% Following Fiscal Q4 Earnings Release Seeking Alpha · November 12, 2026, 15:13 UTC
Pomerantz Law Firm Investigates Artiva Biotherapeutics Following Program Discontinuation and Fatal Safety Events PR Newswire · November 12, 2026, 15:15 UTC
Major Corporate Earnings Scheduled for Release After Thursday Market Close Seeking Alpha · November 12, 2026, 15:00 UTC
U.S. Existing Home Sales Decline More Than Expected in October Seeking Alpha · November 12, 2026, 15:03 UTC
Ascendis Pharma Reports Strong Q3 2026 Results Driven by Yorvipath Growth Motley Fool · November 12, 2026, 15:09 UTC
Pomerantz Law Firm Investigates Omeros Corporation Following Regulatory Setbacks PR Newswire · November 12, 2026, 15:10 UTC
Pomerantz Law Firm Investigates Innodata Inc. Following Mass Layoffs and Stock Price Drop PR Newswire · November 12, 2026, 15:10 UTC